Corrigendum to ‘Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 10 (October), 2020: 105052] (Journal of Stroke and Cerebrovascular Diseases (2020) 29(10), (S1052305720304705), (10.1016/j.jstrokecerebrovasdis.2020.105052))

Solène Hebert, Pierre Clavel, Benjamin Maier, Katsuhiro Mizutani, François Delvoye, Bertrand Lapergue, Malek Ben Maacha, Robert Fahed, Simon Escalard, Jean Philippe Desilles, Hocine Redjem, Gabriele Ciccio, Stanislas Smajda, Benjamin Gory, Sébastien Richard, Raphael Blanc, Michel Piotin, Mikael Mazighi

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret to have forgotten two main authors of the text, Pr Benjamin GORY and Pr Sebastien RICHARD who actively participated with the database of the ETIS Registry and for instance helped in the elaboration of this study. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number105465
JournalJournal of Stroke and Cerebrovascular Diseases
Volume30
Issue number2
DOIs
Publication statusPublished - 2021 Feb
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 10 (October), 2020: 105052] (Journal of Stroke and Cerebrovascular Diseases (2020) 29(10), (S1052305720304705), (10.1016/j.jstrokecerebrovasdis.2020.105052))'. Together they form a unique fingerprint.

Cite this